Paper36969617
Characterization of interventional clinical trials for monkeypox; systematic review of ClinicalTrials.gov database.
Alorfi NM and 2 others. Front Public Health, 2023. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Characterization of interventional clinical trials for monkeypox; systematic review of ClinicalTrials.gov database. Papers, record 36969617. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36969617
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mpox, Monkeypox | Major topic |
| Humans | |
| Africa | |
| Benzamides | |
| Databases, Factual | |
| Europe |
Source PubMed
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35788415 | Vaccination for monkeypox prevention in persons with high-risk sexual behaviours to control on-going outbreak of monkeypox virus clade 3. | Int J Infect Dis | 2022 | https://conductscience.org/library/papers/35788415 | PubMed |
| 2 | 28972544 | Assessing Monkeypox Virus Prevalence in Small Mammals at the Human-Animal Interface in the Democratic Republic of the Congo. | Viruses | 2017 | https://conductscience.org/library/papers/28972544 | PubMed |
| 3 | 35763248 | Prevention and Treatment of Monkeypox. | Drugs | 2022 | https://conductscience.org/library/papers/35763248 | PubMed |
| 4 | 35649575 | Monkeypox: Healthcare workers will be offered smallpox vaccine as UK buys 20 000 doses. | BMJ | 2022 | https://conductscience.org/library/papers/35649575 | PubMed |
| 5 | 35710105 | Monkeypox: WHO to rename disease to prevent stigma. | BMJ | 2022 | https://conductscience.org/library/papers/35710105 | PubMed |
| 6 | 35921403 | Tecovirimat and the Treatment of Monkeypox - Past, Present, and Future Considerations. | N Engl J Med | 2022 | https://conductscience.org/library/papers/35921403 | PubMed |
| 7 | 36274490 | Monkeypox virus vaccine evolution and global preparedness for vaccination. | Int Immunopharmacol | 2022 | https://conductscience.org/library/papers/36274490 | PubMed |
| 8 | 36409451 | Diagnosis, treatment, and prevention of monkeypox in children: an experts' consensus statement. | World J Pediatr | 2023 | https://conductscience.org/library/papers/36409451 | PubMed |
| 9 | 36203212 | Update on the clinical trial landscape: analysis of ClinicalTrials.gov registration data, 2000-2020. | Trials | 2022 | https://conductscience.org/library/papers/36203212 | PubMed |
| 10 | 35973747 | Availability, scope and quality of monkeypox clinical management guidelines globally: a systematic review. | BMJ Glob Health | 2022 | https://conductscience.org/library/papers/35973747 | PubMed |
| 11 | 36039839 | Unprecedented rise of monkeypox in Europe and America: Are Asian countries ready for a new outbreak during the ongoing COVID-19 pandemic? | J Glob Health | 2022 | https://conductscience.org/library/papers/36039839 | PubMed |
| 12 | 21180491 | Hypothesis testing, type I and type II errors. | Ind Psychiatry J | 2009 | https://conductscience.org/library/papers/21180491 | PubMed |
| 13 | 36084881 | A review on insights and lessons from COVID-19 to the prevent of monkeypox pandemic. | Travel Med Infect Dis | 2022 | https://conductscience.org/library/papers/36084881 | PubMed |
| 14 | 35959440 | The importance of pharmacokinetics and pharmacodynamics in antimicrobial drug development and their influence on the success of agents developed to combat resistant gram negative pathogens: A review. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35959440 | PubMed |
| 15 | 36656790 | Epidemiology of Human Mpox - Worldwide, 2018-2021. | MMWR Morb Mortal Wkly Rep | 2023 | https://conductscience.org/library/papers/36656790 | PubMed |
| 16 | 35994281 | Compassionate Use of Tecovirimat for the Treatment of Monkeypox Infection. | JAMA | 2022 | https://conductscience.org/library/papers/35994281 | PubMed |
| 17 | 35777695 | Monkeypox: An extra burden on global health. | Int J Surg | 2022 | https://conductscience.org/library/papers/35777695 | PubMed |
| 18 | 35860122 | Monkeypox has devastated the world; should we prepare for the outbreak of a new pandemic? | Ann Med Surg (Lond) | 2022 | https://conductscience.org/library/papers/35860122 | PubMed |
| 19 | 36423105 | Prevention and Treatment of Monkeypox: A Systematic Review of Preclinical Studies. | Viruses | 2022 | https://conductscience.org/library/papers/36423105 | PubMed |
| 20 | 35860140 | The outbreak of monkeypox 2022: An overview. | Ann Med Surg (Lond) | 2022 | https://conductscience.org/library/papers/35860140 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41428316 | Exploration of the protein and pharmacological landscape of monkeypox virus treatment: from entry point to end point. | Mol Divers | 2026 | https://conductscience.org/library/papers/41428316 | PubMed |
| 40901148 | Potential of MRNA vaccines for mpox prevention: current evidence and future directions. | Ann Med Surg (Lond) | 2025 | https://conductscience.org/library/papers/40901148 | PubMed |
| 38800170 | Monkeypox: From Emerging Trends to Therapeutic Concerns. | Cureus | 2024 | https://conductscience.org/library/papers/38800170 | PubMed |
| 37436275 | In vitro susceptibility of eighteen clinical isolates of human monkeypox virus to tecovirimat. | Mem Inst Oswaldo Cruz | 2023 | https://conductscience.org/library/papers/37436275 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36969617
GET https://conductscience.org/api/papers/v1/36969617/references?page=2